FaReWell Depression – a randomized controlled trial of a physiotherapeutic program for the facial rehabilitation of wellbeing in depression - Summary - MDSpire
Advertisement
FaReWell Depression – a randomized controlled trial of a physiotherapeutic program for the facial rehabilitation of wellbeing in depression
To evaluate the therapeutic potential of the FaReWell Depression program, which aims to improve symptoms of depression through facial rehabilitation targeting emotional expression.
Key Findings:
Significant reduction in depression severity in the intervention group compared to the control group, as measured by the Montgomery-Åsberg Depression Rating Scale (MADRS).
No significant differences in secondary outcome measures, including anhedonia and facial self-perception, indicating the need for further exploration of these aspects.
Interpretation:
The results suggest that a self-applied facial physiotherapeutic intervention may improve symptoms of depression, highlighting the necessity for further investigation into its efficacy and mechanisms.
Limitations:
Small sample size of 49 patients.
Short duration of the intervention (six weeks).
Secondary outcomes did not show significant group differences.
Lack of long-term follow-up to assess the sustainability of the intervention's effects.
Conclusion:
The FaReWell program shows promise as a novel treatment approach for depression, but further research is needed.
by M. Axel Wollmer, Hannah Lemke, Patricia Waldvogel, Insa Neumann, Kayleigh Keller, Veronika Nölle, Nathalie Dittmer, Maksim Lucic, Barbara Walss, Tillmann H.C. Krüger, Josef Hättenschwiler
